pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3689a |
Genomic Coordinates | chr9: 134849487 - 134849564 |
Description | Homo sapiens miR-3689a stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3689a-5p | |||||||||||||||||||||
Sequence | 10| UGUGAUAUCAUGGUUCCUGGGA |31 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TNFAIP1 | ||||||||||||||||||||
Synonyms | B12, B61, BTBD34, EDP1, hBACURD2 | ||||||||||||||||||||
Description | TNF alpha induced protein 1 | ||||||||||||||||||||
Transcript | NM_021137 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TNFAIP1 | |||||||||||||||||||||
3'UTR of TNFAIP1 (miRNA target sites are highlighted) |
>TNFAIP1|NM_021137|3'UTR 1 CCAGACCCTCAGGGAGTCAGGGCACGGGAGGCCCTATCTCCCATCCTGTGGAACCCGCCCCATTGGCCACCCCATGCTGC 81 TGCTGCCTGGGTCTCTGCTCTAGCACCCAGAGGCATGACAGGCCCTGCTCAGAGGTCAGAGGGTCTGGGCAGAGGAGGGA 161 CCACATTCCCCTGCCTTGCCCCTGAGCACTTCTGGAGACTGCGTCCTGTCCTATCTGCTCACCATCACCCTTCCTGCCCG 241 ACGGAGCTGCTTCTGCTCCCTGGGGCATATGGACTGACCCACCTCCTGCTGAGAACCTTCCCCTAGGCCCTGTGCAGAAG 321 GCTACTGCCCCTTAGGCCTCAGCTGGGGGAAAGGCAGTTCTGGTGCTGTAGAGGCCCTGGTGCAGAAAGTGGGACGTCTT 401 TTTTCCTAAGGTGTTTAAGCACAGGCTTGATAAGTTTGGTTTTTAAAAAATAATCTAGGAAATGAATAATTCTAAATCTA 481 GTAATGAGGAAACTGAGCATTTCTTTTGCCCTCCAGGGTGCCAAGACCCTACATATGACAGAACCCTTGGCCCTTCTCCA 561 TGCCTGTGGGATCTGTTTCTTTAAAGCACTTTGTACTGTTATTCAGGAGGTTGATAATCTCCTTGACCCATGTCTTTCTA 641 CCCTAATCCCCACTTCCCTGCAGAATCAATCTGAGGGAGGGGATAAAGAGGAAGCAATAAAAAAAAAACATCCGACAGAG 721 CAGCTCTGGCTTTGCAGCCTGGCCAGCAGCTCAGAGTGCACCGAGGAGGGAAGGATGGCTAAGCTGGGACCGGCAGTCCT 801 CACAGGGTGCCTGTGAGAAAGGACATTTTACCCCCACATCATAGTCACATCACTGACTCCTAGGTCTAGCACGACTGCTC 881 TTTGTGATTCTCTTGAGTACCCTTGGCTTCCAGCCATGCTGTCCTCACATACGGTAAAGCCAAAGAGCTGTCACATGGGC 961 CAGAAACATGAGCCACGGCAGGAAGACCGTGGAGCCCGTGGGCACTGCATGGTGTTGGCTGGCATGCCCATCAGCTGAGG 1041 ACAGCAAACTCCCAGCAGCCCCTACAGAGGTGGCACATGCTTGGCCACACATCTACTCCCTGCCCACACCATCTATGCTC 1121 TTGGTTGGTGCTGGCTGGGATGGCGGTTCTGCCCAGTGGTGTCTCTGAGCGCGGGATGACAGGAGCAACCGAAGCACCCT 1201 GAAGGCCTTCACTCCTTGTTGGGTAACTCAGCCATGGAGATGCCAAGCACTAGCCAGGAGGTGAGTTCCTCTTTAGGGCT 1281 TTGGTTTTCATTCCTTTTTGTTTGGCTTGGCCAAACCAGAATTCAGCTTATCTGAATTATTTTCCAAAGGAATGCTGTCA 1361 GGGAGGGACTGTTCTGCCAGCCTAACAAAGCAACGTAGCCACGTATAGTACCCACTTTCTGCTCTTTGGAGAGAACACAG 1441 GTTATCAAGTTCATCTCTCTTGACTACTCTTATGATAGCTGATGCCACAGAGCCTATGGGCAAATGCCAGACCCAGGGTT 1521 AGACACAAGGACCTGAAGTGACATGACGGCGGGACAGGGGAAATGTGACTTTCTAATTAGGCATTTTATGTTAGTCACAG 1601 TCTTGAATGTATAAACAGCACTAAGACTCTCAGGTCAGGTACCTTGGTGATCAGCTACTAGTTCTTCCAGCCCTCATTGA 1681 GGTAACAAGATAAAGACAAATCCACTTCTTTGGCCAAATTCAGGCTTTGGCTTTATGACTTTCCCACAGAGACTGGAATG 1761 CGTCAGCCTGAGACCACTGGCCTATTTTCTCAGCTGCCCTCTTGAGGTCCTTTAACACTCAAATTCCCAGCTCCCCACTG 1841 AGGTGTTGTGATGCTTGCCTTTTGACCTCCCCATCCCCTTTAGTCCCTGCTTACTACTTTGACATTCACATCCTCAGTGT 1921 CTCAGTCTTTTTTGCCGAGAAAGCACAGTAGTCTGGGACTGGGCATTTATCTTCTCTGACTGAAAATCTCTCCTTGGTCT 2001 TAAGGAAAATACTAACATTGAACTCACTGACATGATCTTAGCTTCTTTAATCAGACTTTGTGACTTAAAAGTTTGGGGGT 2081 TTTCTTTGAAAGTTTCCAGCCCTATTCAGAAAGCAACTCTTGGCTGTGTGCATTTTTCAACTCCAAGCAGCCCAGGGGTA 2161 AGTAAACAAAGTATGGATGAAGGTCAGATTTTCTTGTCAGTTTCTGAGAAACCTGGCAGCCTGCTGTTAACAACACAGGC 2241 CAGTATTGGGTTTTATTGAATTTGGTATGTGACCAAGGTCGGCCTAAAGGATGGCGCAGGTCCTGGGCAGGAAAGAATTT 2321 TTCCTTTATCACATAACTGTAATATTTGGTTGCTCAGCATAAGTGATGGAAGCAAACACTAATTTCTAATAAAATTGTGT 2401 TAAACTCAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000226225.2 | 3UTR | AAUUUUUCCUUUAUCACAUAACUGUAAUAUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
45 hsa-miR-3689a-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT112230 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT188656 | FAM76A | family with sequence similarity 76 member A | 2 | 2 | ||||||||
MIRT200911 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT210595 | KBTBD8 | kelch repeat and BTB domain containing 8 | 2 | 6 | ||||||||
MIRT299207 | CSRNP3 | cysteine and serine rich nuclear protein 3 | 2 | 2 | ||||||||
MIRT317524 | SLC39A7 | solute carrier family 39 member 7 | 2 | 2 | ||||||||
MIRT355849 | SGMS2 | sphingomyelin synthase 2 | 2 | 4 | ||||||||
MIRT443052 | THRB | thyroid hormone receptor beta | 2 | 2 | ||||||||
MIRT446631 | SDC3 | syndecan 3 | 2 | 2 | ||||||||
MIRT449409 | TRIM5 | tripartite motif containing 5 | 2 | 2 | ||||||||
MIRT463561 | ZBTB39 | zinc finger and BTB domain containing 39 | 2 | 6 | ||||||||
MIRT465704 | TNFAIP1 | TNF alpha induced protein 1 | 2 | 2 | ||||||||
MIRT472688 | MYCBP | MYC binding protein | 2 | 4 | ||||||||
MIRT493287 | LNPEP | leucyl and cystinyl aminopeptidase | 2 | 2 | ||||||||
MIRT499338 | RAB25 | RAB25, member RAS oncogene family | 2 | 2 | ||||||||
MIRT501723 | OVOL1 | ovo like transcriptional repressor 1 | 2 | 2 | ||||||||
MIRT507977 | BCL2L13 | BCL2 like 13 | 2 | 4 | ||||||||
MIRT511811 | HDGF | heparin binding growth factor | 2 | 6 | ||||||||
MIRT516711 | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 2 | 4 | ||||||||
MIRT527853 | SMOC1 | SPARC related modular calcium binding 1 | 2 | 2 | ||||||||
MIRT531286 | SLC7A7 | solute carrier family 7 member 7 | 2 | 2 | ||||||||
MIRT531894 | INVS | inversin | 2 | 8 | ||||||||
MIRT536807 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 2 | ||||||||
MIRT537807 | EFNB2 | ephrin B2 | 2 | 4 | ||||||||
MIRT544335 | LPGAT1 | lysophosphatidylglycerol acyltransferase 1 | 2 | 2 | ||||||||
MIRT547142 | PGM3 | phosphoglucomutase 3 | 2 | 2 | ||||||||
MIRT547429 | MED4 | mediator complex subunit 4 | 2 | 2 | ||||||||
MIRT563354 | ZNF181 | zinc finger protein 181 | 2 | 2 | ||||||||
MIRT564849 | ZBED3 | zinc finger BED-type containing 3 | 2 | 2 | ||||||||
MIRT566426 | PIGA | phosphatidylinositol glycan anchor biosynthesis class A | 2 | 2 | ||||||||
MIRT572512 | KIAA0232 | KIAA0232 | 2 | 2 | ||||||||
MIRT574682 | HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 | 2 | 2 | ||||||||
MIRT608820 | ONECUT3 | one cut homeobox 3 | 2 | 6 | ||||||||
MIRT608886 | CLIC6 | chloride intracellular channel 6 | 2 | 2 | ||||||||
MIRT608959 | GIMAP1 | GTPase, IMAP family member 1 | 2 | 4 | ||||||||
MIRT609012 | HPS3 | HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 | 2 | 2 | ||||||||
MIRT641431 | SCUBE3 | signal peptide, CUB domain and EGF like domain containing 3 | 2 | 2 | ||||||||
MIRT661841 | ZNF587B | zinc finger protein 587B | 2 | 2 | ||||||||
MIRT690651 | RPF2 | ribosome production factor 2 homolog | 2 | 2 | ||||||||
MIRT704619 | CLIP1 | CAP-Gly domain containing linker protein 1 | 2 | 2 | ||||||||
MIRT708714 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 1 | ||||||||
MIRT710663 | CSTF2T | cleavage stimulation factor subunit 2 tau variant | 2 | 2 | ||||||||
MIRT711260 | TPCN2 | two pore segment channel 2 | 2 | 2 | ||||||||
MIRT714649 | FSTL1 | follistatin like 1 | 2 | 2 | ||||||||
MIRT718518 | COL19A1 | collagen type XIX alpha 1 chain | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|